300 In the index

LGD-3303 LGD-3303

Another early experimental muscle-building compound from the same research family, studied only in animals for how well it's absorbed and how it affects muscle and bone. Like its relative, it has no human trial history at all.

Also known as LGD3303, 7N4E1X2RJM, RefChem:1074957, LGD 3303, 1196133-39-7, OMXGOGXEWUCLFI-UHFFFAOYSA-N, orb757572, orb3177816, EX-A1672

Effects Build muscle

Routes Oral

Legal status Research chemical

WADA Banned at all times

3D Molecular Structure of C₁₆H₁₄ClF₃N₂O

Drag to rotate · scroll to zoom

Chemistry

Formula: C16H14ClF3N2O
Molar mass: 342.74
CAS: 917891-35-1
PubChem CID: 25195253
IUPAC name: 9-chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-6H-pyrrolo[3,2-f]quinolin-7-one
InChIKey: OMXGOGXEWUCLFI-UHFFFAOYSA-N

Reported dosing

User-reported

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose Not established

Reported range Forum reports: 5-15 mg/day

Route Oral

Frequency Once daily

Duration 6-8 week cycles (unregulated use)

Never completed clinical development; sold only as a research chemical with dosing derived from forums, not clinical data.

Where this comes from User-reported/research-chemical vendor literature; early-stage pharma data only

There is no approved human dosing for this compound. The figures above are what users and vendors report, not what has been established as safe or effective. Treat them as a record of what is done, not as guidance.